Lifastuzumab (Anti-SLC34A2)

Lifastuzumab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. MW : 145.5 KD.
Supplier Selleck Chemicals
Product # A2350
Sku # A2350-1mg*25
Pricing 1mg*25, $5070.00
Feedback